IRS1 and Glucose intolerance: These results implied that LPLM141 intervention significantly mitigated insulin resistance by enhancing the IRS-1/p-AktSer473 insulin signaling pathway and lowering the serum leptin level in high-fat diet-fed rats and subsequently improving glucose intolerance and normalizing the HOMA-IR index.